Get the latest tech news

Therapy chatbot trial yields mental health benefits

Dartmouth researchers conducted the first-ever clinical trial of a generative AI-powered therapy chatbot and found that the software resulted in significant improvements in participants’ symptoms, according to results published March 27 in NEJM AI. People in the study also reported they could trust and communicate with the system, known as Therabot, to a degree that is comparable to working with a mental-health professional.

“The improvements in symptoms we observed were comparable to what is reported for traditional outpatient therapy, suggesting this AI-assisted approach may offer clinically meaningful benefits,” says Nicholas Jacobson, the study’s senior author and an associate professor of biomedical data science and psychiatry at the Geisel School of Medicine. “While these results are very promising, no generative AI agent is ready to operate fully autonomously in mental health where there is a very wide range of high-risk scenarios it might encounter,” says Heinz, who also is an attending psychiatrist at Dartmouth Hitchcock Medical Center. When people initiate a conversation with the app, Therabot answers with natural, open-ended text dialog based on an original training set the researchers developed from current, evidence-based best practices for psychotherapy and cognitive behavioral therapy, Heinz says.

Get the Android app